Recent Finacing
Recent Raise
Endocyte develops oncology therapeutics using a 'drug guidance system' platform to target diseased cells, advancing multiple programs including a Phase 2 ovarian candidate and lung, breast, and kidney treatments.
Focus Areas
Recent Investors
Total Raised
Funding round
Investors
